{
   "title": "Novartis ' spending on research and development by segment 2017 to 2019",
   "labels": [
      "Company",
      "2017",
      "2018",
      "2019"
   ],
   "columnType": "multi",
   "graphType": "bar",
   "summary": [
      "The statistic shows the number of Novartis ' spending research development in Novartis from 2017 to 2019 . ",
      "In 2019 , Innovative_Medicines 's Novartis ' spending research development amounted to Innovative_Medicines ."
   ],
   "trends": [
      {},
      {
         "3": [
            "0",
            "0"
         ],
         "12": [
            "0",
            "0"
         ]
      }
   ],
   "data": [
      {
         "Company": "Innovative Medicines",
         "2017": "7.62",
         "2018": "7.68",
         "2019": "8.15"
      },
      {
         "Company": "Sandoz",
         "2017": "0.77",
         "2018": "0.81",
         "2019": "1.25"
      },
      {
         "Company": "Alcon",
         "2017": "0.58",
         "2018": "0.59",
         "2019": "0"
      }
   ],
   "gold": "This statistic shows the expenditure on research and development of pharmaceutical company Novartis from 2017 to 2019 , by business segment . In 2016 and 2017 , in both years , the company spent around 7.6 billion U.S. dollars for research and development in the Innovative Medicines division .\n"
}